S6E01 – Chasing the Virus: Pandemic-Pace Learning
COVID-19 pandemic is changing the landscape of healthcare. The entire industry is facing a lot of challenges. We need global conversations to shed light on the pandemic’s impact on the different practices and improve the preparedness of healthcare professionals.
Today’s featured guest is Prof. Brian Schwartz, a physician specializing in the treatment of infectious disease. In this episode, Brian discusses the most relevant COVID-19 information. He covers epidemiological updates, viral pathogenesis, clinical condition, diagnostics, therapeutics, and prevention. His presentation is certainly impactful on orthopedic practices.
The phrase ‘knowledge is power’ is very appropriate in the medical field. We should always be learning to have the right perspective and make wise decisions. We need to understand current developments to keep ourselves updated.
Be in the loop! Tune in to Brian’s fantastic presentation.
Today’s Guest
Brian Schwartz is a physician specializing in the treatment of infectious diseases. Currently, he serves as the Vice Chief for Clinical Affairs in the Division of Infectious Diseases in USCF. He’s a dedicated physician and educator. He is a director of UCSF’s infectious diseases clinics, a course director for the Pathogens and Host Defense block in the School of Medicine, the Program Director for the Infectious Diseases Fellowship, Chairs the Medical Education Community of Practice for the Infectious Diseases Society of America, and previously chaired the Microbiology/Immunology Item Writing Committee for the National Board of Medical Examiners.
Schwartz completed his undergraduate degree in biological anthropology at the University of Michigan. He received his medical degree from Rush Medical College and completed an internal medicine residency at Massachusetts General Hospital. He completed a fellowship in infectious diseases at UCSF.
Key Takeaways:
- Structural racism in the health care system leads to significant disparities among patients.
- There are still many areas of growth in terms of understanding COVID-19.
- New data on Remdesivir shows promise
- Strategies for prevention of the spread of COVID-19
Resources:
